BioNxt Solutions Inc.
BNXTF
$0.25
$0.000.00%
OTC PK
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Net Income | -98.25% | -32.26% | -23.90% | 31.69% | -48.45% |
| Total Depreciation and Amortization | -75.00% | -20.00% | -18.37% | 219.51% | -125.15% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 258.19% | 146.51% | -2.88% | -64.10% | 187.54% |
| Change in Net Operating Assets | 170.60% | 111.69% | -676.18% | 130.88% | -135.59% |
| Cash from Operations | 46.18% | 46.58% | -168.53% | 40.22% | -18.30% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | 1,777.78% | -92.35% | 2,615.38% | -97.76% | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | 100.00% | -- | -- | -- |
| Cash from Investing | 1,777.78% | 370.00% | -176.92% | -97.76% | -- |
| Total Debt Issued | -- | -100.00% | -- | -100.00% | 60.66% |
| Total Debt Repaid | -- | -- | 100.00% | 0.00% | -65.30% |
| Issuance of Common Stock | -29.96% | -50.03% | 214.37% | 219.63% | -2.10% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | 100.00% | -106.73% | 691.41% | -62.16% |
| Cash from Financing | -29.80% | -73.12% | 480.06% | -70.71% | 43.79% |
| Foreign Exchange rate Adjustments | -133.33% | 0.00% | -- | -100.00% | 200.00% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 89.51% | -187.93% | 243.65% | -213.54% | 706.45% |